Aspen announces contract manufacturing agreement to initiate local production of Human Insulin for Novo Nordisk at its Gqeberha based sterile manufacturing facility Durban, South Africa – Aspen is pleased to announce further details on one of the contract manufacturing agreements mentioned in its recent announcement of financial results for the year ended 30 June 2023… Continue reading Aspen announces contract manufacturing agreement to initiate local production of Human Insulin for Novo Nordisk at its Gqeberha based sterile manufacturing facility
With the advent of the 2023/24 financial year, we are pleased to present the first Social Economic Development (SED)report, symbolizing a fresh chapter in our commitment to creating a positive organisational and societal impact. This report marks the beginning of another promising journey as we set our sights on a year filled with accomplishments and meaningful progress.
Subject to approval from relevant Competition Authorities, Lilly will enter a strategic agreement with Aspen to continue serving patients and bring innovative therapies to South Africa and the rest of Sub-Saharan Africa. Johannesburg – In an effort to improve the reach and expand the access of its innovative portfolio of medicines to the patients who… Continue reading Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa
Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, is participating in Mandela Day for the 13th consecutive year with more than 60 activities in 23 countries. Stephen Saad, Aspen Group Chief Executive said, “Now, more than ever, communities globally are in desperate need of various… Continue reading Aspen hosts Mandela Day for 13th consecutive year, having reached 865 000 beneficiaries
Dubai, United Arab Emirates – Aspen Healthcare FZ LLC (“Aspen Healthcare”), a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded multinational pharmaceutical company, has entered into a memorandum of understanding (“MOU”) with Saudi Chemical Company Holding (“SCCH”), a well-known company in the local market of the Kingdom of Saudi Arabia, and… Continue reading Aspen, Saudi Chemical Company Holding and its subsidiary AJA Pharma enter into a memorandum of understanding.
Johannesburg – Aspen, a leading global specialty and branded multinational pharmaceutical company, has positively responded to humanitarian calls for relief following the devastating 7.8 magnitude earthquake, along with a series of strong tremors and aftershocks, that tore through southeast Turkey and northwest Syria on 6 February 2023. Stavros Nicolaou, Aspen Group Senior Executive Strategic… Continue reading Aspen donates life-saving emergency relief to patients in Turkey and Syria
An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern Cape, South Africa,
Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first generic antiretroviral (ARV) drug developed and manufactured in Africa. Stephen Saad, Aspen Pharmacare Group Chief Executive Officer said “Aspen-Stavudine is the first locally developed and manufactured generic ARV which presents… Continue reading Aspen manufactures Africa’s first generic ARVs